Technical Analysis for OGEN - Oragenics, Inc.

Grade Last Price % Change Price Change
grade F 0.48 -3.88% -0.02
OGEN closed down 3.88 percent on Friday, May 24, 2019, on 26 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: May 28

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical OGEN trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
20 DMA Resistance Bearish -3.88%
Calm After Storm Range Contraction -3.88%
Fell Below 20 DMA Bearish -3.61%
Spinning Top Other -3.61%
Calm After Storm Range Contraction -3.61%
Earnings Movers Other -3.61%

Older signals for OGEN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Oragenics, Inc., a healthcare company, engages in the discovery, development, and commercialization of various technologies associated with oral health, antibiotics, and other general health benefits in the United States and internationally. It develops ProBiora3, an oral care probiotics technology for oral health, teeth whitening, and breath freshening for humans and pets. The company's ProBiora3 products include flavored probiotic tablets, such as EvoraPlus for daily use by adults and EvoraKids for daily use by children after brushing their teeth; EvoraPet for companion pets, including cats and dogs; and EvoraPro, a professional strength version of EvoraPlus. Its product pipeline consists of LPT3-04, a naturally occurring compound for weight loss; SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay; and MU1140-S, an antibiotic product candidate in preclinical testing for healthcare-associated infections. Oragenics, Inc. offers its ProBiora3 products through direct-to-consumer channels, professional offices, and private label partnerships. The company was formerly known as Oragen, Inc. The company was founded in 1996 and is headquartered in Tampa, Florida.
Medicine Health Healthcare Health Care Antibiotics Antibiotic Healthcare Associated Infections Bacteriology Digestive System Oral Hygiene
Is OGEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.74
52 Week Low 0.38
Average Volume 1,855,014
200-Day Moving Average 0.8055
50-Day Moving Average 0.5659
20-Day Moving Average 0.5078
10-Day Moving Average 0.4957
Average True Range 0.0424
ADX 19.22
+DI 25.6389
-DI 17.5833
Chandelier Exit (Long, 3 ATRs ) 0.4928
Chandelier Exit (Short, 3 ATRs ) 0.5872
Upper Bollinger Band 0.5543
Lower Bollinger Band 0.4613
Percent B (%b) 0.2
BandWidth 18.314297
MACD Line -0.0201
MACD Signal Line -0.0254
MACD Histogram 0.0053
Fundamentals Value
Market Cap 23.65 Million
Num Shares 49.3 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -3.02
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.51
Resistance 3 (R3) 0.51 0.51 0.51
Resistance 2 (R2) 0.51 0.50 0.51 0.50
Resistance 1 (R1) 0.49 0.49 0.49 0.49 0.50
Pivot Point 0.49 0.49 0.49 0.49 0.49
Support 1 (S1) 0.47 0.48 0.47 0.47 0.46
Support 2 (S2) 0.47 0.47 0.47 0.46
Support 3 (S3) 0.45 0.47 0.46
Support 4 (S4) 0.45